Designing of Potential Polyvalent Vaccine Model for Respiratory Syncytial Virus by System Level Immunoinformatics Approaches

Figure 6

The pathological mechanism of RSV explains the entry of RSV via host cell receptors (CX3CR1 and TLRs) into the host cell activating the immune pathways, including MAPK, JAK-STAT, and TLR-associated pathways, leading to the development of different chemokines and cytokines.